Skip to search formSkip to main contentSkip to account menu

Pentaxim

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Pentavac

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Immunogenicity and Safety of a Booster Injection of DTap-IPV//Hib (Pentaxim) Administered Concomitantly With Tetravalent Dengue Vaccine in Healthy Toddlers 15–18 Months of Age in Mexico: A Randomized…
Background: The live, attenuated, tetravalent dengue vaccine (CYD-TDV) is licensed in a number of dengue endemic countries for… 
Review
2012
Review
2012
Вакцина АбКДС-ИПВ//рrр~т: обзор 16-летнего опыта клинического применения
Owing to their low reactogenicity, confirmed efficacy and availability in combination vaccines, acellular pertussis (aP… 
Review
2011
Review
2011
A DTaP–IPV//PRP∼T vaccine (Pentaxim™): a review of 16 years’ clinical experience
Owing to their low reactogenicity, confirmed efficacy and availability in combination vaccines, acellular pertussis (aP… 
2011
2011
Immunogenicity and safety of an acellular pertussis, diphtheria, tetanus, inactivated poliovirus, Hib-conjugate combined vaccine (Pentaxim) and monovalent hepatitis B vaccine at 6, 10 and 14 weeks of…
OBJECTIVE To assess the immunogenicity and safety data for a pentavalent combination vaccine containing acellular pertussis… 
2010
2010
Evaluation of an acellular pertussis, diphtheria, tetanus, inactivated poliovirus, Hib-conjugate combined vaccine (Pentaxim) at 2, 4, and 6 months of age plus hepatitis B vaccine at birth, 2, and 6…
The objective of this study was to evaluate the immunogenicity and safety of a pentavalent vaccine (Pentaxim) containing… 
2009
2009
Immunogenicity and safety of a DTaP-IPV//PRP-T vaccine (Pentaxim) booster during the second year of life in Thai children primed with an acellular pertussis combined vaccine.
This study assessed the booster immune response to a pentavalent combination vaccine containing diphtheria, tetanus, acellular… 
2009
2009
The estimation of safety booster vaccination children is more senior than 1,5 years against diphtheria, perussis, tetanus, poliomyelitis and Haemophilus influenzae type B with Pentaxim.
Supervision over 200 children in the age of 18-42 months (64 healthy and 136 with allergic displays, defeats CNS, often ill, and… 
Review
2008
Review
2008
Molecular Epidemiologic Analysis of Group A Rotaviruses in Children with Diarrhea in Wuhan City, China, 2007
2008
2008
Primary Vaccination of Indian Infants at 6, 10, 14 Weeks of Age with a Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliovirus, Haemophilus Influenzae Type B Conjugate Vaccine (Pentaxim)
2008
2008
Primary Vaccination with a Diphtheria, Tetanus, Acellular Pertussis, Haemophilus Influenzae Type B Conjugate Vaccine (Pentaxim) at 6, 10 and 14 Weeks of Age of Infants in South Africa
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)